Compound Detail
CHEMBL582857
NELIVAPTAN 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
COc1ccc(S(=O)(=O)N2C(=O)[C@@](c3ccccc3OC)(N3C[C@H](O)C[C@H]3C(=O)N(C)C)c3cc(Cl)ccc32)c(OC)c1
Basic Information
| ChEMBL ID | CHEMBL582857 |
| Name | NELIVAPTAN |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | NJXZWIIMWNEOGJ-WEWKHQNJSA-N |
6
Targets
18
Activities
2
Assay Types
5
PK Parameters
20
Publications
5
Known Names
2
Indications
1
Mechanisms
Molecular Properties
630.1
MW (Da)
2.87
ALogP
9
HBA
1
HBD
125.9
PSA (Ų)
0.40
QED
1
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Vasopressin V1b receptor antagonist | ANTAGONIST | Vasopressin V1b receptor | ✓ | ✓ |
Indications
Anxiety Depressive Disorder
Activity Summary
Ki 17 meas. best 9.22
IC50 1 meas. best 5.62
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Vasopressin V1b receptor CHEMBL1921 | Ki | 9.22 | 8.61 | 0.6 | 4 |
| Vasopressin V1b receptor CHEMBL2659 | Ki | 9.0 | 9.0 | 1.0 | 2 |
| Oxytocin receptor CHEMBL2049 | Ki | 8.82 | 7.965 | 1.5 | 4 |
| Vasopressin V1a receptor CHEMBL1889 | Ki | 7.66 | 7.395 | 22.0 | 4 |
| Vasopressin V2 receptor CHEMBL1790 | Ki | 6.54 | 6.5067 | 290.0 | 3 |
| Psychosine receptor CHEMBL3714081 | IC50 | 5.62 | 5.62 | 2392.2 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 343.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 432.0 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 86.67 | mL.min-1.kg-1 | Rattus norvegicus |
| F | 12.0 | % | Rattus norvegicus |
| T1/2 | 0.5 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL5058564 | Fibroblast | 8 |
| - | 10.6019/CHEMBL5058564 | U2OS | 6 |
| 20400305 | 10.1016/j.bmcl.2010.03.108 | ADMET | 4 |
| 21605973 | 10.1016/j.bmcl.2011.03.012 | Rattus norvegicus | 4 |
| 20400305 | 10.1016/j.bmcl.2010.03.108 | Unchecked | 3 |
| - | 10.6019/CHEMBL5209801 | C5a anaphylatoxin chemotactic receptor 1 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 21605973 | 10.1016/j.bmcl.2011.03.012 | Liver microsomes | 2 |
| - | 10.6019/CHEMBL5209801 | Type-1 angiotensin II receptor | 2 |
| - | 10.6019/CHEMBL5209801 | N-formyl peptide receptor 2 | 2 |
| - | 10.6019/CHEMBL5209801 | Sphingosine 1-phosphate receptor 1 | 2 |
| - | 10.6019/CHEMBL5209801 | G-protein coupled receptor 35 | 2 |
| 19800231 | 10.1016/j.bmcl.2009.09.050 | Vasopressin V1b receptor | 2 |
| 21353540 | 10.1016/j.bmcl.2010.12.081 | Vasopressin V1b receptor | 2 |
| - | 10.6019/CHEMBL5209801 | CX3C chemokine receptor 1 | 2 |
| - | 10.6019/CHEMBL5209801 | Adhesion G-protein coupled receptor F1 | 2 |
| - | 10.6019/CHEMBL5209801 | Apelin receptor | 2 |
| - | 10.6019/CHEMBL5209801 | Free fatty acid receptor 4 | 2 |
| - | 10.6019/CHEMBL5209801 | Glucagon-like peptide 1 receptor | 2 |
| - | 10.6019/CHEMBL5209801 | Alpha-2A adrenergic receptor | 2 |
Data from ChEMBL 36 via Core Engine